Earnings Feed
Start Free
|4Mar 21, 4:06 PM ET

Branning Todd P. 4

4 · NeuBase Therapeutics, Inc. · Filed Mar 21, 2022

Insider Transaction Report

Form 4
Period: 2022-03-18
NeuBase Therapeutics, Inc.NBSE
Branning Todd P.
Chief Financial Officer
Transactions
  • Purchase

    Common stock

    2022-03-18$1.81/sh+10,000$18,100→ 30,000 total

Documents

1 file
  • 4
    tm2210039-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT